CONTRAFECT Corp

/CONTRAFECT Corp

We are a clinical-stage biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious diseases, particularly those treated in hospital-based settings.

Symbol

Last Closing Price
$0.29

Shares
30,000,000

Anticipated Date
December 10, 2019

Underwriters

This offering is no longer available

To view the prospectus for , or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange